한글목차

세계 연속 타정 라인 시장 전망은 바이오 의약품, 경구용 고형제, 건강 제품 시장에서 기회가 있을 것으로 보입니다. 세계 연속 타정 라인 시장은 2025-2031년 3.6%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다. 이 시장의 주요 촉진요인은 개인 맞춤형 의료와 복잡한 약물 제제의 채택이 확대되고 있으며, 제조 아웃소싱 증가 추세에 따른 것입니다.

• Lucintel의 예측에 따르면, 유형별로는 연속이 예측 기간 동안 높은 성장을 이룰 것으로 예측됩니다.
• 용도별로는 바이오의약품이 가장 높은 성장이 예상됩니다.
• 지역별로는 북미가 예측 기간 동안 가장 규모가 큰 지역이 될 것으로 예측됩니다.

연속 타정 라인 시장의 새로운 트렌드

연속 타정 라인 시장은 기술, 품질 관리, 시장 수요의 변화의 지속적인 발전을 반영하여 몇 가지 새로운 트렌드가 형성되고 있습니다. 이는 의약품 제조의 효율성, 확장성, 지속가능성을 높이기 위한 업계 변화의 주요 원동력이 되고 있습니다.

• 인더스트리 4.0 기술 통합: 연속 타정 라인은 IoT, AI, 머신러닝 등 인더스트리 4.0 기술과 통합되고 있습니다. 이러한 추세는 실시간 모니터링, 자동화, 데이터 분석을 강화하고, 프로세스 효율성을 높이고, 다운타임을 줄이고, 제품 품질을 향상시킬 수 있습니다.
• 지속적인 품질 개선의 중요성: 고도의 품질 관리 시스템과 실시간 모니터링을 통해 가능한 지속적인 품질 개선이 현재 주목받고 있습니다. 이러한 추세는 제품의 품질을 보장하고, 규제 기준을 유지하며, 제조 과정에서 적극적인 조정을 가능하게 하는 역할을 하고 있습니다.
• 신흥 시장 진출: 아시아, 라틴아메리카 등 신흥 시장에서의 의약품 수요 증가에 따라 기업들은 이 지역으로 사업을 확장하고 있습니다. 이러한 추세의 배경에는 의약품 수요 증가와 경제 상황의 개선으로 인해 기업들이 이 지역에서 새로운 수익원을 찾고 생산 능력을 보다 효율적으로 활용할 수 있게 되었기 때문입니다.
• 모듈형 시스템 및 확장형 시스템 개발: 유연성과 적응성으로 인해 모듈형 및 확장형 연속 타정 시스템 개발에 큰 추진력이 있습니다. 이러한 시스템은 모듈식 빌딩 블록을 추가하고 효과적인 생산의 필요에 따라 재구성하여 쉽게 확장할 수 있기 때문에 제조업체는 효율적으로 사업을 확장하고 시장 변화에 빠르게 대응할 수 있습니다.
• 지속 가능하고 친환경적인 제조에 집중: 지속 가능하고 친환경적인 제조에 대한 트렌드가 점점 더 강화되고 있습니다. 기업들은 에너지 소비를 줄이고, 폐기물을 최소화하고, 환경 친화적 인 재료를 사용하는 데 집중함으로써 환경에 이익을 가져다주고 규제 준수 및 기업의 사회적 책임 프로파일을 향상시키고 있습니다.

이러한 새로운 트렌드에 따라 연속 타정 라인 시장에서도 효율성, 품질, 지속가능성을 중시하는 큰 변화가 일어나고 있습니다. 이러한 추세를 도입하는 기업은 세계 제약시장에서 경쟁력을 유지하면서 변화하는 시장 수요에 대응할 수 있을 것으로 보입니다.

연속 타정 라인 시장의 최근 동향

연속 타정 라인 시장의 최신 주요 발전은 제약 제조 공정을 혁신하기 위한 기술 변화와 전략적 행동을 보여줍니다. 이러한 변화는 더 높은 효율성, 혁신성, 국경을 초월한 확장으로 향하는 업계의 성장을 반영합니다.

• 연속 타정 라인의 안정성과 일관성을 향상시키기 위해 점점 더 진보된 공정 제어 시스템이 채택되고 있습니다. 이러한 첨단 공정 관리 시스템에는 실시간 데이터 수집, 즉각적인 자동 조정, 생산의 변동성 최소화, 전반적인 생산성 향상 등의 기능이 포함되어 있습니다.
• 이 개발은 연속 제조 플랫폼의 출현으로 이어집니다. 여러 생산 단계를 하나의 공정으로 통합하는 다용도 연속 제조 플랫폼이 광범위하게 개발되고 있습니다. 그 결과, 일괄 처리를 줄임으로써 제조 공정을 단순화하고, 속도와 효율성을 향상시켜 전체 생산량을 개선할 수 있습니다.
• 공동 R&D 이니셔티브의 성장: R&D에서 제약회사와 기술 제공업체의 협력은 공동 R&D 이니셔티브의 혁신을 촉진합니다. 이러한 공동 개발을 통해 보다 빠르고 진보된 연속 타정 기술을 개발하여 업계의 요구를 충족시키는 새로운 솔루션을 구축할 수 있습니다.
• 연속 타정 라인 설비의 세계 진출: 미래의 의약품 수요 급증에 대비하여 생산 능력을 세계화하기 위해 기업들은 자사 시설에 연속 타정 라인을 설치하여 세계 진출을 도모하고 있습니다.
• 맞춤형 솔루션 도입: 특정 의약품 생산 요건을 충족하는 특수한 연속 타정 솔루션도 개발되고 있습니다. 맞춤형 시스템을 통해 생산자는 고유한 과제에 대처할 수 있는 유연성과 성능을 향상시키고 전체 생산 공정을 강화할 수 있습니다.

연속 타정 라인 시장의 이러한 새로운 발전은 기술 재편, 용량 확대 및 효율성 향상을 가져오고 있습니다. 이러한 개발 기회를 받아들이는 기업은 제조 공정을 개선하고 세계 시장에서 효과적으로 경쟁할 수 있는 유리한 위치에 있습니다.

목차

제1장 주요 요약

제2장 시장 개요

• 배경과 분류
• 공급망

제3장 시장 동향과 예측 분석

• 업계 촉진요인과 과제
• PESTLE 분석
• 특허 분석
• 규제 환경

제4장 세계의 연속 타정 라인 시장 : 유형별

• 개요
• 유형별 매력 분석
• 연속 : 동향과 예측(2019-2031년)
• 반연속 : 동향과 예측(2019-2031년)

제5장 세계의 연속 타정 라인 시장 : 용도별

• 개요
• 용도별 매력 분석
• 바이오의약품 : 동향과 예측(2019-2031년)
• 경구 고형제 : 동향과 예측(2019-2031년)
• 건강 제품 : 동향과 예측(2019-2031년)
• 기타 : 동향과 예측(2019-2031년)

제6장 지역 분석

• 개요
• 세계의 연속 타정 라인 시장 : 지역별

제7장 북미 연속 타정 라인 시장

• 개요
• 북미 연속 타정 라인 시장 : 유형별
• 북미 연속 타정 라인 시장 : 용도별
• 미국 연속 타정 라인 시장
• 멕시코 연속 타정 라인 시장
• 캐나다 연속 타정 라인 시장

제8장 유럽 연속 타정 라인 시장

• 개요
• 유럽 연속 타정 라인 시장 : 유형별
• 유럽 연속 타정 라인 시장 : 용도별
• 독일 연속 타정 라인 시장
• 프랑스 연속 타정 라인 시장
• 스페인 연속 타정 라인 시장
• 이탈리아 연속 타정 라인 시장
• 영국 연속 타정 라인 시장

제9장 아시아태평양 연속 타정 라인 시장

• 개요
• 아시아태평양 연속 타정 라인 시장 : 유형별
• 아시아태평양 연속 타정 라인 시장 : 용도별
• 일본 연속 타정 라인 시장
• 인도 연속 타정 라인 시장
• 중국 연속 타정 라인 시장
• 한국 연속 타정 라인 시장
• 인도네시아 연속 타정 라인 시장

제10장 기타 지역 연속 타정 라인 시장

• 개요
• 기타 지역 연속 타정 라인 시장 : 유형별
• 기타 지역 연속 타정 라인 시장 : 용도별
• 중동 연속 타정 라인 시장
• 남미 연속 타정 라인 시장
• 아프리카 연속 타정 라인 시장

제11장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter의 Five Forces 분석
  • 경쟁 기업간 경쟁 관계
  • 바이어의 교섭력
  • 공급 기업의 교섭력
  • 대체품의 위협
  • 신규 진출업체의 위협
• 시장 점유율 분석

제12장 기회와 전략 분석

• 밸류체인 분석
• 성장 기회 분석
  • 유형별 성장 기회
  • 용도별 성장 기회
• 세계 연속 타정 라인 시장의 새로운 동향
• 전략 분석
  • 신제품 개발
  • 인증 및 라이선싱
  • 합병, 인수, 계약, 제휴, 합병사업

제13장 밸류체인 전체 주요 기업 개요

• Competitive Analysis
• GEA
• Hovione
• Fette Compacting
• IMA Pharma
• Coperion K-Tron
• KORSCH
• Syntegon

제14장 부록

• 도표
• 표 리스트
• 조사 방법
• 면책사항
• 저작권
• 약어와 기술 단위
• 미국에 대해
• 미국 문의

영문목차

The future of the global continuous tableting line market looks promising with opportunities in the biopharmaceutical, oral solid dosage form, and health products markets. The global continuous tableting line market is expected to grow with a CAGR of 3.6% from 2025 to 2031. The major drivers for this market are the growing adoption of personalized medicine & complex drug formulations and the rising trend of outsourcing manufacturing.

• Lucintel forecasts that, within the type category, continuous is expected to witness higher growth over the forecast period.
• Within the application category, biopharmaceutical is expected to witness the highest growth.
• In terms of region, North America will remain the largest region over the forecast period.

Emerging Trends in the Continuous Tableting Line Market

Several emerging trends shape the Continuous Tableting Line market, reflecting continuous developments in technology, quality control, and changes in market needs. These are major drivers of change in the industry towards higher efficiency, scalability, and sustainability in pharmaceutical manufacturing.

• Integration of Industry 4.0 Technologies: Continuous tableting lines are integrating with Industry 4.0 technologies, such as IoT, AI, and machine learning. This trend enforces real-time monitoring, automation, and data analytics, which enhance process efficiency, reduce downtime, and improve product quality.
• More Emphasis on Continuous Quality Improvement: Continuous quality improvement, made possible through the use of advanced quality control systems and real-time monitoring, is now a focus of attention. This trend is responsible for ensuring product quality, maintaining regulatory standards, and enabling proactive adjustments during manufacturing.
• Expanding into Emerging Markets: With the increasing demand for pharmaceuticals in emerging markets, such as Asia and Latin America, companies are expanding their operations into these areas. The rationale behind this trend is the increasing demand for pharmaceuticals and economic improvement that enable companies to seek additional revenue streams and better utilize production capacity in these regions.
• Development of Modular and Scalable Systems: Due to their flexibility and adaptability, there is great momentum in the development of modular and scalable continuous tableting systems. Such systems can easily be expanded by adding modular building blocks and reconfiguring them based on the necessities for effective production, which allows manufacturers to scale operations efficiently and quickly respond to market changes.
• Focus on Sustainable and Green Manufacturing: The trend is increasingly toward sustainable and green manufacturing. Companies focus on reducing energy consumption, minimizing waste, and using environmentally friendly materials, thereby benefiting the environment and improving their regulatory compliance and corporate social responsibility profiles.

With these emerging trends, significant changes are being driven in the market for Continuous Tableting Line, emphasizing efficiency, quality, and sustainability. Companies embracing these trends will be well-placed to meet changing market demands while remaining competitive in the global pharmaceutical market.

Recent Developments in the Continuous Tableting Line Market

The latest key developments in the Continuous Tableting Line market reveal a shift in technology and strategic actions to transform the pharmaceutical manufacturing process. These changes reflect the industry's growth toward greater efficiency, innovation, and expansion across borders.

• Increasingly advanced process control systems are being adopted to achieve improved stability and consistency with continuous tableting lines. These advanced process control systems include features such as real-time data acquisition, immediate automated adjustments, minimization of variability in production, and a boost to overall productivity.
• This development leads to the emergence of continuous manufacturing platforms. Multi-use continuous manufacturing platforms are being widely developed that integrate several production stages into one process. Consequently, this simplifies manufacturing processes by reducing batch processing, thus improving overall production through increased speed and efficiency.
• Growth in Collaborative R&D Initiatives: The collaboration of pharmaceutical companies with technology providers in research and development fosters the innovation of collaborative R&D initiatives. Such collaboration develops advanced continuous tableting technologies with higher velocities and allows for the building of new solutions to meet industry needs.
• Global Expansion into Continuous Tableting Line Facilities: Companies seek global expansion with continuous tableting lines at their facilities to prepare for future demand surges in pharmaceuticals and to globalize their production capabilities.
• Introduction of Custom Solutions: Specialty continuous tableting solutions for specific pharmaceutical production requirements are also being developed. In turn, customized systems will afford producers greater flexibility and performance in addressing unique challenges, enhancing the production process as a whole.

These new developments in the Continuous Tableting Line market are realigning technology, expanding capabilities, and enhancing efficiencies. Companies embracing these development opportunities are better positioned to improve their manufacturing processes and compete effectively in the global marketplace.

Strategic Growth Opportunities in the Continuous Tableting Line Market

Several strategic growth opportunities exist in different applications within the Continuous Tableting Line market. These prospects point to possibilities for enhanced production and market expansions, reflecting changes in pharmaceutical and nutraceutical needs.

• Continuous Processes: Continuous tableting lines offer an opportunity to advance pharmaceutical product development. Continuous processes simplify production and make it more scalable, which will accelerate new drug and formulation developments, keeping pace with the rapid advancements in the pharmaceutical industry.
• Personalized Medicine: Personalized medicine is growing, and continuous tableting systems will have the chance to expand by adopting this system, as it produces small and customized batches of tablets. This ability will meet the demand for tailored treatments and thus improve patient outcomes with personalized solutions.
• Manufacturing of Biopharmaceuticals: Continuous tableting lines are increasingly being used in the manufacturing of biopharmaceuticals to support the production of complex formulations with high-quality standards. This application helps meet stringent regulatory requirements and enhances production efficiency.
• Nutraceutical Manufacturing: Continuous tableting lines represent effective and scalable production solutions in the flourishing nutraceutical industry. This application addresses the fast-growing demand for nutritional supplements and functional foods, leading to better ways of ensuring improved production and quality enhancement of products.
• Emerging Market Expansion: Growth opportunities in emerging market expansion for continuous tableting lines include advancing companies into new markets created by the growth of the pharmaceutical and nutraceutical industries in regions like Asia and Latin America, utilizing advanced production technologies to handle increased demand.

Driven by these strategic growth opportunities, innovation and efficiency are likely to mark the path of the Continuous Tableting Line market development. With these initiatives targeted at the highlighted areas of focus, companies in this space are poised to improve their production capabilities, better adapt to changing market requirements, and achieve growth.

Continuous Tableting Line Market Driver and Challenges

The dynamics of the Continuous Tableting Line market show the range of drivers and challenges that various influencing technological, economic, and changing regulatory factors bring forth. Understanding these factors serves as a good navigational tool through the complexities in the market while leveraging growth opportunities.

The factors responsible for driving the continuous tableting line market include:

• Technological Changes: Advances in continuous tableting technology have been significant growth drivers that drastically improve efficiency and product quality. Advanced systems with real-time monitoring and automation reduce production variability and enhance overall performance.
• Economic Pressures: The development of more cost-effective continuous tableting solutions drives economic pressures. Companies need to lower production costs while increasing profitability, which also calls for the use of more efficient manufacturing processes.
• Regulatory Changes: Changing regulatory conditions will significantly impact the design and implementation of continuous tableting lines. Companies need to navigate the regulatory landscape carefully to comply with complex regulations, lest their production improvements come to a standstill.
• Efficiency Demand: The growing demand for effective manufacturing processes propels firms toward continuous tableting lines. This trend calls for technologies that ensure greater productivity while reducing production time to remain competitive.
• Sustainability Emphasis: Emphasizing sustainable practices is expected to help develop green continuous tableting solutions. Reducing energy consumption and minimizing waste will be major attributes considered by companies for environmental and regulatory compliance.

Challenges in the continuous tableting line market are:

• System Integration Complexity: Continuous tableting lines require considerable integration, especially in existing batch-based production environments. Integrating newer technology with legacy systems may be complex, leading to higher initial investments and longer setup times.
• High Initial Capital Investment: Although continuous tableting lines generate savings in the long run, the high upfront investment required tends to deter many small and medium-sized pharmaceutical companies. The financial burden could discourage companies from adopting the technology, especially in cost-sensitive markets.
• Stringent Regulatory Compliance: Despite encouragement from regulators, continuous manufacturing in pharmaceuticals demands high levels of compliance. Regulatory approval for new processes can take a long time and is expensive to achieve and maintain, particularly in regions with complex regulatory structures.

These key drivers and challenges are transforming technology adaptation and operational strategies associated with the Continuous Tableting Line market and its regulatory compliance. Companies positioned to address these factors will be well-placed to prosper in an evolving market landscape.

List of Continuous Tableting Line Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies continuous tableting line companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the continuous tableting line companies profiled in this report include-

• GEA
• Hovione
• Fette Compacting
• IMA Pharma
• Coperion K-Tron
• KORSCH
• Syntegon

Continuous Tableting Line by Segment

The study includes a forecast for the global continuous tableting line market by type, application, and region.

Continuous Tableting Line Market by Type [Analysis by Value from 2019 to 2031]:

• Continuous
• Semi-continuous

Continuous Tableting Line Market by Application [Analysis by Value from 2019 to 2031]:

• Biopharmaceutical
• Oral Solid Dosage Form
• Health Products
• Others

Continuous Tableting Line Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Continuous Tableting Line Market

Recent trends in the Continuous Tableting Line market reflect a growing emphasis on efficiency, scalability, and technological advancement in pharmaceutical production. These changes indicate a clear move toward integrated and automated manufacturing, where diverse companies across different regions face new challenges and opportunities.

• United States: In the U.S., the adoption of continuous tableting lines is increasing. Continuous tableting lines can enhance efficiency and reduce production costs. Major pharmaceutical companies are investing in sophisticated systems by adopting real-time monitoring and automation to support smooth manufacturing.
• China: The capacity for continuous tableting lines is growing rapidly in China due to government policies aimed at modernizing pharmaceuticals. This has catalyzed several companies to embrace the technology, ensuring high production efficiency and quality products at international levels, thereby enhancing China's position as a key player in the global market.
• Germany: The German pharmaceutical industry is heavily investing in continuous tableting technologies to maintain competitiveness. Emphasis is placed on integrating these systems, allowing for precision, waste reduction, and adherence to strict European regulations, which together enhance production efficiency.
• India: Continuous tableting lines are boosting India's pharmaceutical manufacturing, enabling it to meet high demand levels on the international stage while improving compliance with international standards. Investing in these systems is a sure way to enhance scalability and efficiency in operations.
• Japan: Continuous tableting lines are being incorporated in Japan due to increasing demand for high-quality pharmaceuticals. Japanese companies are considering advanced technologies to enhance production, ensuring consistent quality that satisfies both domestic and international markets.

Features of the Global Continuous Tableting Line Market

• Market Size Estimates: Continuous tableting line market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Continuous tableting line market size by type, application, and region in terms of value ($B).
• Regional Analysis: Continuous tableting line market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the continuous tableting line market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the continuous tableting line market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the continuous tableting line market by type (continuous and semi-continuous), application (biopharmaceutical, oral solid dosage form, health products, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Continuous Tableting Line Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 Continuous: Trends and Forecast (2019-2031)
• 4.4 Semi-continuous: Trends and Forecast (2019-2031)

5. Global Continuous Tableting Line Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Biopharmaceutical: Trends and Forecast (2019-2031)
• 5.4 Oral Solid Dosage Form: Trends and Forecast (2019-2031)
• 5.5 Health Products: Trends and Forecast (2019-2031)
• 5.6 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global Continuous Tableting Line Market by Region

7. North American Continuous Tableting Line Market

• 7.1 Overview
• 7.2 North American Continuous Tableting Line Market by Type
• 7.3 North American Continuous Tableting Line Market by Application
• 7.4 United States Continuous Tableting Line Market
• 7.5 Mexican Continuous Tableting Line Market
• 7.6 Canadian Continuous Tableting Line Market

8. European Continuous Tableting Line Market

• 8.1 Overview
• 8.2 European Continuous Tableting Line Market by Type
• 8.3 European Continuous Tableting Line Market by Application
• 8.4 German Continuous Tableting Line Market
• 8.5 French Continuous Tableting Line Market
• 8.6 Spanish Continuous Tableting Line Market
• 8.7 Italian Continuous Tableting Line Market
• 8.8 United Kingdom Continuous Tableting Line Market

9. APAC Continuous Tableting Line Market

• 9.1 Overview
• 9.2 APAC Continuous Tableting Line Market by Type
• 9.3 APAC Continuous Tableting Line Market by Application
• 9.4 Japanese Continuous Tableting Line Market
• 9.5 Indian Continuous Tableting Line Market
• 9.6 Chinese Continuous Tableting Line Market
• 9.7 South Korean Continuous Tableting Line Market
• 9.8 Indonesian Continuous Tableting Line Market

10. ROW Continuous Tableting Line Market

• 10.1 Overview
• 10.2 ROW Continuous Tableting Line Market by Type
• 10.3 ROW Continuous Tableting Line Market by Application
• 10.4 Middle Eastern Continuous Tableting Line Market
• 10.5 South American Continuous Tableting Line Market
• 10.6 African Continuous Tableting Line Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunities by Type
  • 12.2.2 Growth Opportunities by Application
• 12.3 Emerging Trends in the Global Continuous Tableting Line Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis
• 13.2 GEA
  • Company Overview
  • Continuous Tableting Line Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 Hovione
  • Company Overview
  • Continuous Tableting Line Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 Fette Compacting
  • Company Overview
  • Continuous Tableting Line Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 IMA Pharma
  • Company Overview
  • Continuous Tableting Line Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 Coperion K-Tron
  • Company Overview
  • Continuous Tableting Line Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.7 KORSCH
  • Company Overview
  • Continuous Tableting Line Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.8 Syntegon
  • Company Overview
  • Continuous Tableting Line Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us